Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.

beta2-Glycoprotein I (beta2GPI), a plasma glycoprotein with phospholipid-binding property, is known to be the actual target antigen for autoimmune type anticardiolipin antibodies (aCLs). Certain groups of aCLs (anti-beta2GPI antibodies) exert lupus anticoagulant (LA) activity and perturb the functio...

詳細記述

書誌詳細

出版年:	J Clin Invest
主要な著者:	Takeya, H., Mori, T., Gabazza, E. C., Kuroda, K., Deguchi, H., Matsuura, E., Ichikawa, K., Koike, T., Suzuki, K.
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Clinical Investigation 1997
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC508058/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9151800/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI119401
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!